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Abstract
Mitochondria are major cellular sources of hydrogen peroxide (H2O2), the production of which is modulated by oxygen
availability and the mitochondrial energy state. An increase of steady-state cell H2O2 concentration is able to control the
transition from proliferating to quiescent phenotypes and to signal the end of proliferation; in tumor cells thereby, low H2O2
due to defective mitochondrial metabolism can contribute to sustain proliferation. Mitogen-activated protein kinases (MAPKs)
orchestrate signal transduction and recent data indicate that are present in mitochondria and regulated by the redox state. On
these bases, we investigated the mechanistic connection of tumor mitochondrial dysfunction, H2O2 yield, and activation of
MAPKs in LP07 murine tumor cells with confocal microscopy, in vivo imaging and directed mutagenesis. Two redox conditions
were examined: low 1 mMH 2O2 increased cell proliferation in ERK1/2-dependent manner whereas high 50 mMH 2O2 arrested
cell cycle by p38 and JNK1/2 activation. Regarding the experimental conditions as a three-compartment model (mitochondria,
cytosol, and nuclei), the different responses depended on MAPKs preferential traffic to mitochondria, where a selective
activation of either ERK1/2 or p38-JNK1/2 by co-localized upstream kinases (MAPKKs) facilitated their further passage to nuclei.
As assessed by mass spectra, MAPKs activation and efficient binding to cognate MAPKKs resulted from oxidation of conserved
ERK1/2 or p38-JNK1/2 cysteine domains to sulfinic and sulfonic acids at a definite H2O2 level. Like this, high H2O2 or directed
mutation of redox-sensitive ERK2 Cys
214 impeded binding to MEK1/2, caused ERK2 retention in mitochondria and restricted
shuttle to nuclei. It is surmised that selective cysteine oxidations adjust the electrostatic forces that participate in a particular
MAPK-MAPKK interaction. Considering that tumor mitochondria are dysfunctional, their inability to increase H2O2 yield should
disrupt synchronized MAPK oxidations and the regulation of cell cycle leading cells to remain in a proliferating phenotype.
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Introduction
The cell’s redox status controls the progression of the cell cycle,
including misregulation in cancer [1,2]. Oxidants, such as H2O2,
play an important role in the activation of signaling molecules,
which control the complex machinery involved in cell prolifera-
tion, differentiation, apoptosis, and senescence. An attractive
notion is that the continuous increase in oxidant concentration
may trigger disparate cell responses: slight variations in H2O2
concentration (0.7–20 mMH 2O2) help determine normal cell fate,
i.e., proliferation [3,4], arrest, senescence or apoptosis [5].
Moreover, an increase in H2O2 steady-state concentration
([H2O2]ss) has been observed in vivo in the transition from
proliferative hepatoblasts to quiescent and differentiated hepato-
cytes [6].
Mitochondria are major cellular sources of H2O2, the production
of which is modulated by the mitochondrial energy state and
generation of nitric oxide [7]. High mitochondrial H2O2 yield is
associated with late rat brain and liver development and signals the
end ofproliferation [6,8].From thisperspective,development can be
understood as a transition from anaerobic metabolism to a five-fold
increase in metabolism in mature cells; arrest and differentiation are
associated to high mitochondrial activity and membrane potential
[9]. Mitochondria are dysfunctional in cancer: the activity of
mitochondrial complexes is decreased, the mitochondrial generation
of H2O2 is substantially decreased [10], the mitochondrial-K
+
channel axis is suppressed [11], the oxidant-dependent inhibition
p38 MAPK is impaired, and p53 suppresses mitochondrion-driven
apoptosis [12]. Hence, it may be surmised that tumor cells –alike
embryonic tissues– live at a very low [H2O2]ss [6,10,13].
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protein kinases (MAPKs) [14]. MAPKs are proline-directed serine/
threonine kinases [15] that have been classified into at least six
subfamilies; from these, ERK1/2, JNK1/2, and p38 are the most
extensively studied. ERK1/2 is normally activated by growth signals
[16,17]; JNK1/2 and p38 respond to oxidative stress, heat shock,
ionizing radiation, and UV light [18,19], and are mainly associated
with cell cycle arrest and apoptosis. Of note, oxidative stress may be
viewed as a potential carcinogen due to the activation of NFkBo r
Akt pathways or by causing DNA mutations [20,21]. MAPKs are
specifically regulated by a MAPK kinase (MAPKK) [22], i.e.,
ERK1/2 is activated by MEK1/2, p38 by MKK3, and JNK1/2 by
MKK4, among others. MAPKs are sensitive to redox changes:
ERK1/2, p38, and JNK1/2 are activated in a variety of cellular
systems at different H2O2 concentrations [23,24]. We previously
reported that high phosphorylated ERK1/2 content is associated
with proliferation and low [H2O2]ss in proliferating embryonic and
tumoral tissues, while tumor arrest requires high [H2O2]ss with
predominant p38 and JNK1/2 activation [6,10].
To understand the mechanisms of redox modulation by
MAPKs, studies have been focused on the oxidative inhibition
of phosphatases (MKP) [25] and on the interaction of MAPKKs
with antioxidant proteins, such as thioredoxin [26]. However, the
direct effects of oxidants on MAPKs and the mechanisms of the
transition from proliferation to arrest remain obscure.
Recent data indicate that MAPKs are present in mitochondria,
as well as other kinases like PKC and Akt [27,28]. However, the
connection among tumor mitochondrial dysfunction, H2O2 yield,
and activation of MAPKs still awaits elucidation. In the present
work, we provide evidence of MAPKs subcellular redistribution
upon activation, including their transit through mitochondria. We
demonstrate that the redox state modulates the mitochondrial
interaction of MAPKs to MAPKKs by oxidation of conserved
cysteine domains of MAPKs to sulfinic and sulfonic acid; this
biochemical mechanism determines MAPKs differential activation
and traffic to nuclei and ultimately, sustains the phenotype of LP07
tumor cells.
Results
H2O2 drives opposite effects on tumor cell cycle
progression and signaling
P07 tumorcells show verylow [H2O2]ss(10
211 M)likeembryonic
and proliferating tissues [6,10]. In these cells, mitochondria have a
low H2O2 production rate but they still respond to oxidative stress as
the normal ones do [6,10]. In the present study, we thus examined
the redox transition as represented by low (1 mM) and high (50 mM)
H2O2 concentrations. This transition offers the opportunity to test a)
the circuit of redox signaling based upon mitochondria and, b) a
mechanistic of low H2O2 yield for persistent cell proliferation. We
showinFigure1Athat1 mMH 2O2increasedLP07cellproliferation
by about 20% (p,.05) while 50 mMH 2O2 oppositely resulted in
40% decrease of cell proliferation (p,.05). To evaluate if 50 mM
H2O2 caused cell cycle arrest or apoptosis, we performed Annexin V
staining by flow cytometry. Annexin V-propidium iodide double-
negative cells indicated that high H2O2 concentration triggered a
transition to a low proliferative state but not to apoptosis, as plotted
in Fig. 1B.
The cell cycle modulation by H2O2 described herein was
orchestrated by MAPKs. At low H2O2, redox-induced cell
proliferation was almost abolished by ERK1/2 inhibitor U0126.
Instead, cell cycle arrest observed with 50 mMH 2O2 was
specifically mediated by activation of p38 and JNK1/2 as shown
in Fig. 1C by utilizing SB202129 (p38 inhibitor) or SP600125
(JNK1/2 inhibitor). As inferred by the effect of U0126, the
temporal increase of cyclin D1 observed with 1 mMH 2O2
depended as well on the activation of ERK1/2, while downreg-
ulation of cyclin D1 at 50 mMo fH 2O2 was reverted by the p38
and JNK1/2 inhibitors (Fig. 1C and D). It is concluded that cell
cycle variations are related to the differential redox activation of
extracellular or stress activated MAPK.
Mitochondria are a meeting point of MAPKs and their
upstream activators
Activation of MAPKs in response to a variety of stimuli, including
oxidative stress [19,29] has been defined in a two-compartment
system: phosphorylation (activation) in cytosol followed by translo-
cation to nuclei [16,30]. Preliminary data on MAPK mitochondrial
turnover and its modulation by redox status [24,31] prompted us to
examineathree-compartmentmodelforMAPKredistributionupon
activation in LP07 cells. To confirm the presence of MAPKs in
LP07, cells were labeled with MitoTracker Deep Red and immune
stained with anti ERK1/2, p38, and JNK1/2 primary antibodies
and secondary antibodies conjugated with Cy3. Images were
obtained by confocal microscopy and further analyzed by intensity
correlationanalysis(ICA)[32](Fig.2A);thepresenceofadiagonalin
the 2D fluorescence intensity histogram demonstrated that MAPKs
are constitutively expressed in mitochondria. Furthermore, mito-
chondrial subfractionation showed that MAPKs colocalized with
their cognates MEK1/2, MKK3 and MKK4 in the mitochondrial
outer membrane and in the intermembrane space (Fig. 2B), as
corroborated by the different fraction markers. ERK1/2 molecules
were also detected within the organelles by electron microscopy
(Fig. 2C).
Traffic of MAPKs and MAPKKs elicited by redox
stimulation involves the mitochondrial compartment
Comparison of the activation kinetics and nuclear accumulation
of ERK1/2, JNK1/2, and p38 upon oxidative perturbation
yielded a remarkable difference in MAPK responses. After
stimulation with 1 mMH 2O2, p-ERK1/2 and total ERK1/2
increased in mitochondria, cytosol and nuclei (Fig. 3). An hour
after stimulation, p-ERK1/2 returned to the basal level in
mitochondria but remained elevated in nuclei. Conversely,
50 mMH 2O2 entailed a considerable lower rate of ERK1/2
translocation and reduced its activation by ten-fold, and the kinase
was retained in mitochondria in detriment of nuclear accumula-
tion (Fig. 3). The sum of the kinetics integrals for each H2O2
treatment remained constant (Fig. 3, circled numbers) which
emphasizes the notion of redox interdependence between the
mitochondrial and nuclear compartments.
A similar approach to assess the redox regulation of the kinetics
JNK1/2 and p38 (Fig. 4) revealed that these were barely affected
at low (1 mM) H2O2 levels. Instead, upon treatment with 50 mM
H2O2, total and phosphorylated JNK1/2 and p38 increased in
mitochondria and cytosol and then translocated and accumulated
in the nuclei (Fig. 4).
In order to assess the in vivo translocation of MAPKs into
mitochondria, LP07 cells were transfected with either GFP-
hERK2 or GFP-hJNK1, stained them with MitoTracker Deep
Red, and continuously followed for MAPK redistribution upon
H2O2 stimulation by video confocal microscopy. Low H2O2
caused GFP-hERK2 entrance to mitochondria and subsequent
translocation to nuclei (Fig. 5A). A similar behaviour but at high
H2O2 stimulation was found for GFP-hJNK1 (Fig. 5B). In the
right panel of Figure 5, fluorescence values were plotted every
minute during 40 min. In both redox conditions, a previous
Redox Mitochondrial MAPKs
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however, in the experimental conditions, GFP-hJNK1 turnover
resulted faster than that of GFP-hERK2. The patterns described
by confocal microscopy were similar to those observed by western
blot in Figs. 3 and 4.
The subcellular redistribution of MAPKKs and their redox
regulation are shown in Fig. S1. 1 mMH 2O2 stimulus elicited an
initial MEK1/2 outward movement from mitochondria to cytosol
(Fig. S1A). As ERK1/2, p-MEK1/2 was retained in mitochondria
when stimulated with 50 mMH 2O2. MEK1/2 translocation to
nuclei could not be detected in agreement with previous reports
[29,33].
The pattern of redistribution and activation of MKK4 (Fig.
S1B) and MKK3 (Fig. S1C) following stimulation with high H2O2
mimicked that of MEK1/2 at 1 mMH 2O2, i.e., the MAPKKs
moved out from the mitochondria to the cytosol. Fig. S1D is a
scheme representative of putative cycle of upstream MAPKKs in
the studied conditions to carry up MAPKs to nucleus. The degree
of MAPK nuclear retention is related to cell cycle progression
[16,33]; ERK1/2 retention correlates to cell proliferation, while
retention of JNK1/2 and p38 correlates with cell cycle arrest (see
Figs. 1 and 2).
Oxidation favors differential MAPKs phosphorylation in
vitro, but does not change the intrinsic catalytic activity
Direct effects of H2O2 on MAPK catalytic activity were assessed
with human recombinant ERK2-GST or immunoprecipitated
JNK1/2 and p38 immobilized on agarose. Kinases exposed to
Figure 1. Redox dual modulation of cell fate depends on the activation of ERK1/2 or p38 and JNK1/2. (A) Cells were counted up to 48 h
after stimulation with 1 mM (purple), 50 mM (yellow) or no H2O2 (blue) (mean6s.e.m; n=3, experiment representative of 3, * p,0.05 respect to
control values by ANOVA and Scheffe comparison test). (B) Apoptosis was determined by propidium iodide staining (upper panel) and Annexin V
(lower panel) by flow cytometry 48 h after H2O2 treatment. (C) [
3H] thymidine incorporation was measured 48 h after supplementing LP07 cells with
1 mM (purple), 50 mM (yellow) or no H2O2 (blue) (C=control) (mean6s.e.m; n=8, experiment representative of 5, *p,0.05 respect to control values
by ANOVA and Scheffe comparison test). When appropriate, cells were preincubated 2 h prior to stimulation with ERK1/2 (U0126), p38 (SB202190) or
JNK1/2 (SP600125) inhibitors. (D) Cyclin D1 expression was determined 1 to 3 h after H2O2 treatment (upper panels), and 2 h after stimulation in the
presence of MAPK inhibitors as in (C) (medium and lower panels).
doi:10.1371/journal.pone.0002379.g001
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kinases and
32P-cATP. Phosphorylation efficiency of ERK2 by
MEK1/2 was enhanced at low H2O2 concentrations, whereas
decreased at high H2O2 concentration (Fig. 6A). Oppositely,
phosphorylation of JNK1/2 and p38 by respective MKK4 and
MKK3, was enhanced at high H2O2 level (Fig. 6A). However,
H2O2 treatments did not affect the intrinsic catalytic activity of
ERK2, JNK1/2, or p38 as proved by absence of effects on the
phosphorylation of myelin basic protein (substrate for ERK1/2) or
ATF-2 (substrate for p38 and JNK1/2) (Fig. 6A). We therefore
surmise that exposure of ERK2, JNK1/2, and p38 to determined
H2O2 concentrations increases phosphorylation efficiency by
introducing a post-translational modification that would enhance
the interaction with their respective MAPKKs.
To see whether phosphorylation efficiency varies by redox
effects on binding, we treated recombinant MAPKs with 0.1–
10 mMH 2O2, and subsequently incubated them with cytosolic or
mitochondrial fractions containing the respective MAPKKs.
Similarly to phosphorylating activities, ERK2-GST binding to
MEK1/2 resulted enhanced at low H2O2 level (0.1 mMH 2O2)
(Fig. 6B) whereas p38-GST and JNK2-GST binding to cognate
MAPKKs was facilitated at 10 mMH 2O2 (Fig. 6B). Interestingly,
oxidation of ERK2-GST enhanced its dimerization and activation
as shown by the interaction with endogenous ERK1/2 and the
increase in phosphorylation (Fig. 6B). However, these interactions
and ERK2 activation were enterely disrupted at H2O2 concen-
trations above 1 mM.
H2O2 modulates ERK-MEK interaction and shuttle to
nuclei
To examine whether redox effects on binding in vivo resemble
the ones observed in vitro, LP07 cells were stimulated with 1 and
Figure 2. MAPKs and MAPKKs localize in tumor mitochondria. (A) LP07 cells were stained with MitoTracker Deep Red, fixed and immune
stained with anti ERK1/2, JNK1/2 and p38 primary antibodies and secondary antibodies conjugated with Cy3, and analyzed in an Olympus FV1000
confocal microscope. Images directly exported from Olympus Fluoview acquisition program were processed with DIP image software for MATLAB,
and a 2D fluorescence intensity histogram was performed. Pixel frequency map displayed on the right. Bar=10 mm. (B) Submitochondrial localization
of MAPKs and MAPKKs was assessed by western blot. (M: mitochondria; Mpl: mitoplast; OMM: outer mitochondrial membrane; IMS: intermembrane
space; IMM: inner mitochondrial membrane; Mx: mitochondrial matrix). Identity of mitochondrial fractions was corroborated with specific antibodies
anti complex I 39 kDa subunit, voltage-dependent anion channel (VDAC1), superoxide dismutase II and cytochrome oxidase, subunit VI C. (C) ERK1/2
was detected in LP07 mitochondria by immune labelling and transmission electron microscopy.
doi:10.1371/journal.pone.0002379.g002
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mitochondria, and cytosol and complex formation was followed by
western blot in a pull-down assay. As observed in the in vitro assay,
in vivo p-MEK1/2-ERK1/2 interaction was substantially increased
at low H2O2 and decreased at high H2O2 concentration (Fig. 7A).
To investigate whether modulation of MEK-ERK interaction in
mitochondria affects shuttle to nuclei, cells were transfected with
ERK2 and its mutants H230R or Y261N, both with restricted
docking to MEK1/2 [33]. At low H2O2, transfected ERK2 wild
type followed a typical sequence of translocation to mitochondria
and nucleus as shown in Figures 2 and 5A. Oppositely, ERK2
mutants with poor binding to MEK1/2 were retained in the
organelles in detriment of their translocation to nuclei (Fig. 7B).
These findings suggest that the traffic of MAPKs to the nuclei and
thus, cell behaviour, depend on H2O2-induced changes in their
loop of activation, as resulted from redox variations in the domains
docking the upstream MAPKKs in mitochondria [34,35].
ERK2, p38, and JNK2 cysteine thiols are specifically
oxidized by H2O2
Considering the susceptibility to oxidation of cysteine thiol
moieties in proteins, we explored the relevance of these amino
acids in the regulation of MAPKs pathways. ERK2-GST
immobilized on agarose was exposed to the thiol blocker 4-vynil-
pyridine (4-VP) and then incubated with a mitochondrial fraction.
4-vinylpyridine treatment resulted in a markedly reduced ERK-
MEK interaction (Fig. 8A).
Oxidized cysteines responsible for the differential binding of
MAPKs were identified by LC/MS/MS. After treatment with
low H2O2 concentrations (0.1 mM), the thiol groups of ERK2
Cys
38 and Cys
214 were oxidized to sulfinic (–SO2H) and sulfonic
acid (–SO3H). No oxidation of ERK2 cysteines was detected
following treatment with high H2O2 concentrations (10 mM)
(Table 1).
No JNK2 cysteines were oxidized with 0.1 mMH 2O2, while
1 mMH 2O2 oxidized the thiols of Cys
41, Cys
137, Cys
177, and
Cys
222 to –SO2H, and Cys
116 to –SO3H. It is remarkable that
JNK2 Cys
41, homologous to ERK2 Cys
38, was sensitive to
oxidation while JNK2 Cys
213, homologous to ERK2 Cys
214, was
not oxidized at any H2O2 level. In contrast, p38 Cys
162,
homologous to an alternative docking domain of rat ERK1/2,
was oxidized to –SO3H only after 20 mMH 2O2 (Table 1). No
methionine, histidine, or tryptophan oxidation, or tyrosine and
tryptophan nitrosylation were detected.
ERK-MEK interaction and ERK shuttle to nuclei depend on
mitochondrial oxidation of the redox-sensitive cysteines
In order to assess the role of oxidizable cysteines on ERK
activation and redistribution, ERK2 mutants C38A, C214A, and
C214E were transfected onto LP07 cells to search for their
interaction with MEK1/2. H2O2 oxidation enhanced wild type
ERK2-MEK1/2 interaction (Fig. 8B), as was previously observed
in Fig. 6B. However, H2O2 had no effect on the interaction of
MEK1/2 with ERK2 when Cys
214 was substituted by an Ala
(C214A) (Fig. 8B). ERK2-MEK1/2 interaction was otherwise
enhanced by the replacement of Cys
214 with a Glu (C214E), even
in the absence of H2O2 (Fig. 8B).
Wild type ERK2 translocated to mitochondria and was
afterwards retained in nuclei after stimulation with 1 mMH 2O2,
as endogenous ERK (Fig. 8C and see Fig. 3). In contrast, ERK2
mutants C38A and C214A were retained in mitochondria in
detriment of nuclear entrance (Fig. 8C). p-MEK1/2 was as well
retained in mitochondria after transfection with ERK2 mutants
C38A and C214A, which indicates that defective oxidation
impedes ERK-MEK complex exit from mitochondria (Fig. 8D).
ERK redox-sensitive cysteine domains are well conserved in all
MAPKs as well as in other kinases (Table 2). Noteworthy is the
fact that both oxidable Cys
38 in ERK2 and Cys
41 in JNK2 are in
Figure 3. Kinetics of ERK1/2 activation and subcellular redistribution upon redox stimuli. Temporal activation and distribution of ERK1/2
and p-ERK1/2 in the subcellular fractions was followed by western blot. Red and grey circles correspond to 1 and 50 mMH 2O2, respectively; each
point integrates densitometries from three separate experiments. Circled numbers represent areas under the curve in arbitrary units per minute
calculated with Graph Pad Prism 5 software. A western blot representative of 3 independent experiments is shown. Protein loading was determined
with antibodies anti cytochrome oxidase subunit VI C for mitochondria, b-actin for cytosol, and nuclear antigen (PCNA) for nuclei.
doi:10.1371/journal.pone.0002379.g003
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H2O2 levels. JNK2 Cys
213 and p38 Cys
48 and Cys
231 all present in
these domains, were not oxidized.
Discussion
In the present study we provide evidence that supports that H2O2
drives proliferation and cell cycle arrest by specific MAPKs
activation in LP07 cells. Opposite effects elicited by low and high
H2O2 concentrations have been previously observed in various
tumor celllines [10], as wellas innormal tissues [6]; this supports the
notion that increases in H2O2 concentrations change cell phenotype
by eliciting sequential and opposite responses [3]. This process relies
on the alternative activation of either ERK1/2 or JNK1/2 and p38
MAPKs by modulation of the interaction with their cognate
MAPKKs. We also confirm the presence of MAPKs and MAPKKs
in mitochondria and that these kinases redistribute to the cytosolic
and nuclear compartments. The mechanism of MAPK import onto
the outer membrane and intermembrane space still awaits
elucidation [36]. MAPKs could enter and exit the organelle without
previous mitochondrial damage, alike Bcl-2 or Bcl-xL, both
mitochondrial proteins that translocate to nuclei [37,38].
We show for the first time that modulation of MAPKs
interaction with their upstream kinases relies on the oxidation of
Figure 4. Kinetics of JNK1/2 and p38 activation and subcellular redistribution upon redox stimuli. Temporal activation and distribution
of JNK1/2 and p38 was followed as in Fig. 3, in analogue experimental conditions.
doi:10.1371/journal.pone.0002379.g004
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remarkable finding is that selective kinase activation is based on a
differential sensitivity to oxidants, particularly H2O2. Further-
more, efficient ERK2 binding to MEK is achieved by oxidation of
two of the five ERK2 cysteine thiols, Cys
38 and Cys
214, to cysteine
sulfinic (-SOH2) and sulfonic (-SOH3) acid at very low H2O2.
Interestingly, ERK2 Cys
38 and Cys
214 are not oxidized at high
H2O2. A great variability in the oxidation of cysteine residues at
high H2O2 concentration was previously found; this fact could be
due to the molecular reorganization and competition with water,
induced by the oxidant itself. Noteworthy is that JNK2 Cys
41,
homologous to ERK2 Cys
38, was sensitive to oxidation while
JNK2 Cys
213, homologous to ERK2 Cys
214, was not oxidized at
any H2O2 level. On the other hand, p38 Cys
162, homologous to an
alternative docking domain of rat ERK1/2, was oxidized to –
SO3H only at high H2O2 concentrations (20 mM).
ERK2 cysteine oxidation by H2O2 proceeds outside its catalytic
site, increases binding to MEK1/2 by three to four-fold, modulates
activity, and, more importantly, it does not occur at every H2O2
concentration, for it can only be achieved at low oxidant level.
Cysteine post-translational modifications appear to be critical for
the ERK activation pathway and kinase redistribution, and
Figure 5. Imaging of MAPKs in vivo. (A) LP07 cells stained with MitoTracker Deep Red and transfected with GFP-hERK2 and stimulated with 1 mM
H2O2, or (B) transfected with GFP-JNK1 and stimulated with 50 mMH 2O2 were imaged in vivo. In (A) and (B) on the right, turnover of MAPKs was
monitored with a mask done on the mitochondria with the MitoTracker, or by appearance of GFP green fluorescence in the nucleus. Changes of
fluorescence were graphicated when MitoTracker intensity and the respective GFP fluorescence were over 20 in these areas. Images were taken every
minute for 40 minutes. Bar=10 mm.
doi:10.1371/journal.pone.0002379.g005
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immuneprecipitated JNK1/2 and p38 were oxidized for 15 min with H2O2 and then incubated 30 min with their upstream kinases (MEK1/2, MKK4 or
MKK3, respectively), or their substrates, myelin basic protein (MBP) or ATF-2, respectively, in the presence of
32P-cATP. Total protein content for
MAPKKs and MAPKs assessed by western blot. Mock experiment (M) was done as control in which the phosphorylating kinases (MAPKK or MAPK,
respectively) were omitted. Asterisk denotes p,0.05 respect to control values by ANOVA and Scheffe comparison test. (B) Human recombinant ERK2-
GST, JNK2-GST or p38-GST were immobilized on agarose, oxidized with H2O2 and incubated with cytosolic or mitochondrial fractions. Interaction with
MAPKKs was detected by western blot.
doi:10.1371/journal.pone.0002379.g006
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214 to Ala rendered ERK2
and MEK1/2 accumulation in mitochondria, also observed under
high H2O2 concentration.
Modulation of enzyme activity by cysteine oxidation to sulfenic
acid has been reported: thiol oxidation has been shown to
participate in the catalytic mechanism of peroxiredoxins (Prx)
isoforms I-VI, which reduce H2O2 by forming disulphide [39],
sulfenic acid (in Cys
51 in mammals) [40,41]. Prxs are further
oxidized to sulfinic acid and inactivated [42], the same that
MAPK phophatase-3 [43] and phosphatase-1B [44]. The cysteine
sulfinic acid of Prxs can be reduced to cysteine by ATP-dependent
sulfiredoxin [45] or sestrins-Hi95 or sestrin2 [46]. Together, these
facts argue for the reversible oxidation of cysteines as a mechanism
of protein activation.
The domains surrounding the cysteines susceptible to oxidation
in the former enzymes share an Arg residue (Cys+6 to Cys+11)
[47] as well as those in MAPKs. Thiol oxidation requires a low
pKa for the cysteine group [48]. When located in position Cys+10
or Cys+9, Arg helps decrease pKa below 5.8 (normal Cys
pKa=8.5), to dissociate Cys–SH to the thiolate (Cys–S
–)a t
physiological pH, and to stabilize cysteine sulfinic oxidation.
Because mutation of Cys
214 to glutamic acid enhances ERK-MEK
interaction, negative charges must be involved in the interaction
and thus, we postulate that cysteine oxidation introduces negative
Figure 7. Redox state adjusts MEK-ERK interaction and regulates traffic from mitochondria to nuclei in vivo. (A) p-MEK1/2 and p-ERK1/2
were immunoprecipitated from mitochondrial or cytosolic extracts of H2O2 stimulated cells, run on SDS-PAGE and stained with anti MEK1/2, p-MEK1/
2, ERK1/2 and p-ERK1/2 antibodies; bars are mean6s.e.m.; n=3, western blot representative of 3 independent experiments displayed on the left, and
densitometries on the right. Asterisk denotes p,0.05 respect to control values by ANOVA and Scheffe comparison test. (B) Cells were transfected with
wild type (WT) ERK2, or ERK2 mutants H230R or Y261N, both with reduced binding capacity to MEK1/2 [33]. After incubation with H2O2,
mitochondrial and nuclear fractions were isolated, and ERK2 distribution was detected by western blot using an anti Flag antibody. A western blot
representative of 3 independent experiments is shown. Complex IV and PCNA were used as loading control.
doi:10.1371/journal.pone.0002379.g007
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[48]. An attractive idea is that charged cysteines lead MEK or
other ligands as they ‘‘walk’’ through arginines to Asp
316 and
Asp
319 (Fig. 9A and B), the two essential ERK acidic residues that
integrate the D domain for binding to ligands [32]. p38 Cys
162
negative charges might be attracted to the arginines of upstream
ligands, like Arg
104 of MKK3 [49]. With respect to JNK, the
probable mechanism of redox binding is controversial, for
Figure 8. ERK interaction with MEK and efficient shuttle to nuclei critically depend on the oxidation of ERK Cys
38 and Cys
214. (A)
hERK2-GST cysteines were blocked with 4-vinylpyridine (4-VP), and the protein oxidized and subsequently incubated with a mitochondrial fraction as
in Fig. 8. (B) Cells were transfected with wild type (WT) ERK2 or ERK2 mutants C38A, C214A, and C214E and stimulated with 1 mMH 2O2 for 15 min.
ERK2 was immunoprecipitated with an anti Flag antibody from isolated mitochondria, and complexes were run on SDS-PAGE and stained with an anti
MEK1/2 antibody. (C) Kinetics of differential mitochondrial and nuclear distribution of transfected wild type and ERK2 mutants were followed by
western blot after 1 mMH 2O2 treatment. (D) Kinetics of mitochondrial distribution of p-MEK1/2 when cells were transfected with ERK2 WT, C38A or
C214A.
doi:10.1371/journal.pone.0002379.g008
Table 1. Mass spectrometry analysis of ERK2, p38 and JNK2 cysteine modification by H2O2
MAPK H2O2 (mM) Tryptic peptide Residue Charge MSc XC Dcn
ERK2 0.1 YTNLSYIGEGAYGMVC(O3)SAYDNLNK Cys
38 2 34 3.4 0.2
YTNLSYIGEGAYGMVC(O2)SAYDNLNK Cys
38 3 NA 5.3 0.13
SIDIWSVGC(O2)ILAEMLSNRPIFPGK Cys
214 2 NA 2.9 0.26
p38 20 DLKPSNLAVNEDC(O3)ELK Cys
162 3 63 3.2 0.27
JNK2 1 YQQLKPIGSGAQGIVC(O3)AAFDTVLGINVAVK Cys
41 2 98 5.1 0.67
TLEEFQDVYLVMELMDANLC(O3)QVIHMELDHER Cys
116 35 4 N A N A
MSYLLYQMLC(O3)GIK Cys
137 2 31 1.4 0.2
TAC(O3)TNFMMTPYVVTR Cys
177 2 35 2.8 0.41
GC(O3)VIFQGTDHIDQWNK Cys
222 2 37 2.7 0.06
MAPK were oxidized with H2O2. Tryptic peptide fragment sequence, peptide charge, Mascot Ions Score (MSc), Sequest XC and Dcn value are shown. Dcn stands for the
difference in the cross-correlation score between the top two candidate peptides or proteins for a given input data file. NA: not assigned. No oxidation was achieved
with ERK2 at 10 mMH 2O2, with JNK2 at 0.1 mMH 2O2 or with p38 at ,10 mMH 2O2.( O 3) sulfonic modification, (O2) sulfinic modification.
doi:10.1371/journal.pone.0002379.t001
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possibility that oxidation of multiple cysteines may stabilize the
hydrophobic interactions involved in the binding capacity of
proteins and also suggests that more than one model of regulation
by oxidation could apply for the different biological systems and
molecular pathways.
We conclude that proliferation of LP07 cells, and presumably in
other cellular systems, depends on sustained oxidation of ERK2
thiols to sulfinic or sulfonic acid achieved at low oxidant yield. If
dysfunctional mitochondria are incapable of increasing the
oxidative level in cells [10], then they cannot contribute to cell
cycle arrest either by oxidation of p38 Cys
162 or by impeding
Cys
38 and Cys
214 oxidation in ERK2 and, thus, drive to an
uncontrolled cell division and ultimately to cancer.
Materials and Methods
Cell line, culture conditions and treatments
LP07 cell line was derived from P07 lung tumor spontaneously
arisen in a BALB/c mouse, and extensively characterized [10,50].
Cells were maintained in Dulbecco’s modified Eagle’s medium
nutrient mixture F-12 HAM (D-MEM) with 10% fetal bovine
serum (FBS) and 50 mg/ml gentamycin. For treatment, cells were
24 h serum starved and then stimulated with H2O2 and/or the
MAPKs inhibitors (2 h prior to H2O2 treatment). When
appropriate, cells were seeded onto a 22.1-mm diameter well
and transiently transfected with wild-type 3XFlag-CMV7-ERK2
vector, the ERK2 mutants H230R and Y261N (kindly provided
by Dr. M. Cobb) or ERK2 mutants C38A, C214A and C214E
(Genscript, Piscataway, NJ, USA), with Lipofectamine 2000
(Invitrogen) according to manufacturer’s instructions. After
transfection, cells were stimulated and harvested, and subcellular
fractions were recovered for western blot.
Isolation of nuclear, mitochondrial and cytosolic fractions
Cells were lysed in MSHE buffer (0.22 M mannitol, 0.07 M
sucrose, 0.5 mM EGTA, 2 mM HEPES/KOH, 1 mM phenyl-
methylsulfonylfluoride (PMSF), 5 mg/ml leupeptin, 5 mg/ml pep-
statin, 5 mg/ml aprotinin, 25 mM NaF, and 1 mM sodium
orthovanadate, pH 7.4). The homogenate was centrifuged 10 min
at 10006g (pellet=crudenuclearextract) and20 minat 10,0006g
(pellet=mitochondria; supernatant=cytosol). Mitochondria were
resuspended in MSHE. The crude nuclear extract was washed with
buffer A (10 mM Tris, 1.5 mM EDTA, 10% glycerol, 1mM PMSF,
5 mg/ml leupeptin, 5 mg/ml pepstatin, 5 mg/ml aprotinin, 5 mM
NaF, and 1 mM sodium orthovanadate, pH 7.4) containing 0.01%
NP-40, resuspended in buffer A plus 0.4 M KCl, and incubated
30 min at 4uC. The suspension was centrifuged 30 min at 1050006
g and diluted with buffer A to reduce salt concentration. The purity
of the fractions was assessed by western blot with antibodies against
complex I or IV (mitochondria), by measuring lactate dehydroge-
nase activity (cytosol), and by flow cytometry with propidium iodide
(nuclei) (data not shown). Protein content was determined by Lowry
method.
Table 2. Redox sensitive cysteine domains.
JNK1 61 IGSGAQGIVCAAYD JNK1 273 VDIWSVGCIMGEMV
JNK2 32 IGSGAQGIVCAA FD JNK2 207 VDIWSVGCIMGLV
ERK2 31 EGAYGMVCAAYD ERK2 207 IDIWSVGCIMGEMV
ERK1 51 EGAYGMVSAAYD ERK1 227 VDIWSVGCILAEML
p38 40 GSGAYGSVCAAYD p38 224 VDIWSVGCIMGEMV
1PME 91 GEGAYGIVCSAYD 1PME 229 IDIWSVGCIMGEMV
MMK1 51 IGHGAIGI VCSAHN MMK1 185 IDIWSVGCIMGEMV
MPK1 20 GEGAYGIVCSAYD MPK1 162 DVWSVGCIMGEMV
1TKIA 4 LGREFGIVCAAYD 1TKIA 193 TDIWSTGVIMGEMV
PHKA 3 LGRGVSVVCIH PHKA 215 DVWSVGCIMGEMV
Alignment of homologue sequences corresponding to regions surrounding
Cys
38 and Cys
214 of ERK2 in different kinases.
Aligment performed with Expasy Proteomics Server (www.ca.expasy.org). 1PME
(penta mutant ERK2); MMK1 (mitogen-activated protein kinase homolog); MPK1
(mitogen-activated protein kinase); 1TKIA (human titin kinase); PHKA (human
phosphorylase kinase subunit alpha).
doi:10.1371/journal.pone.0002379.t002
Figure 9. Scheme of electrostatic guide for ERK-MEK interac-
tion based on cysteine charges. (A) MKP3-ERK2 interaction based
on a crystallographic study (PDB 2GPH). MKP3 peptide is placed on
ERK2 docking groove as a product of acidic and hydrophobic
interactions with oxidizable cysteines (in red) (modelled with the PyMol
program; DeLano Scientific, CA, USA). (B) Scheme based on (A)
representing the ligand (yellow ovals) approaching ERK2 (green circles).
The ligand ‘‘walks’’ through acidic charges, attracted by Cys
38 and
Cys
214, to finally reach the common docking domain [54].
doi:10.1371/journal.pone.0002379.g009
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Proteins separated by SDS-PAGE, were transferred onto PVDF
membranes and immunoblotted with antibodies anti total and
phosphorylated ERK1/2, p38, JNK1/2, MEK1/2, MKK3,
MKK4 (Cell Signaling), cyclin D1 (Santa Cruz), complex I and
IV (Molecular Probes) or Flag (Sigma), and then incubated with
secondary antibodies conjugated with horseradish peroxidase (GE
Health Care). Chemiluminiscence was detected with enhanced
ECL reagent (GE Health Care).
Proliferation assays
LP07 cells were seeded onto a 96-well plate (8.10
4 cells/well)
and treated as described above for 48 h in the presence of
0.8 mCi/well [
3H] thymidine (specific activity, 70 to 90 Ci/mmol;
NEN/Dupont, Boston, MA). Then cells were harvested and
radioactivity measured in a liquid scintillation counter (Wallac
1414, Turku, Finland). Alternatively, LP07 cells seeded onto a 24-
well plate (1.10
5 cells/well) and treated as above, were harvested
by trypsinization and counted in a Neubauer chamber in the
consecutive days after stimulation.
Cell growth assay
LP07 were seeded onto a 24-well plate, treated as above, and
then harvested and counted in a Neubauer chamber in the
consecutive days after stimulation.
Cell cycle and apoptosis assays
Treated cells were harvested and incubated with (i) 100 mg/mL
propidium iodide in 0.1% sodium citrate, 0.1% Triton X-100 at
4uC overnight in the darkness [51] or (ii) Annexin V-FITC
(Immunotech) according to manufacturer’s instructions. Cells were
run on a FACScalibur flow cytometer (Becton-Dickinson,
Mountain View, CA) and analyzed with WinMDI software for
windows.
Fluorescence labeling and confocal microscopy
Cells were grown on cover slides and stained with a specific
mitochondrial marker, MitoTracker Deep Red 633 FM (Molec-
ular probes) (100 nM, 45 min at 37uC), fixed in 4% paraformal-
dehyde, blocked in 1% BSA, 0.3% Triton X-100, PBS, pH 7.4, in
a humidified chamber for 1 h, and incubated with primary (anti
ERK1/2, JNK1/2 or p38) antibodies and secondary antibodies
conjugated with Cy3 for 1h at RT in the same buffer. Cover slides
were mounted in Fluorsave mounting media (Calbiochem). For in
vivo imaging, cells were grown on Lab-Tek Chambered Borosil-
icate Coverglass System (Nunc), and transfected with GFP-hERK2
or JNK1-GFP, and stained with Mitotracker as described above.
Confocal laser scanning microscopy was performed with an
Olympus FV1000 using a 6361.35 NA oil immersion objective.
Excitation filters and emission detected with a PDA device were as
follows: GFP, 488 nm excitation, 500–560 nm emission; Cy3,
532 nm excitation, 580610 nm emission; MitoTracker Deep
Red, 633 nm excitation, 650–750 nm emission. Images were
acquired with Olympus Fluoview FV10-ASW software and
analyzed with DIP image software for MATLAB (TNO, Delft).
Images were analyzed by intensity correlation analysis (ICA) [51];
if two structures are part of the same complex or are present at the
same place, then their staining intensities should vary in
synchrony, whereas if they are on different complexes or structures
they will exhibit asynchronous staining. ICA was done with
MATLAB software as already developed, studied and reported
[52]. Live images were analyzed as follows: a mask was done over
the nucleus or over mitochondria when MitoTracker intensity was
over 20, and GFP fluorescence was followed in these areas as well
as in the whole cell. Nuclear and mitochondrial GFP fluorescence
intensity was corrected for total photobleaching.
Immune-electron microscopy
Cells were fixed in 4% paraformaldehyde and 0.5% glutaral-
dehyde in phosphate buffer 0.2 M pH 7.4 for 4 h. After washing
in 0.1% glycine the samples were dehydrated in ethanol and
embedded in LR White as described [6]. Samples were labeled
overnight with anti p-ERK1/2 antibody diluted 1:10, and then
washed in 1% BSA and 0.05% Tween in PBS. Then they were
incubated with a secondary antibody (1:50) conjugated with
10 nm colloidal gold particles (Sigma anti-rabbit IgG) for 1 h at
RT. Grids were washed, fixed in 2% glutaraldehyde for
10 minutes and counterstained in 2% uranyl acetate. Samples
were analyzed on a Zeiss EM-C10 transmission electron
microscope (506 and 1006 objective) at 80k and photographed
with 35 mm Kodak electron film.
Co-immunoprecipitation assay
MAPKs were immunoprecipitated from cytosolic or mitochon-
drial fractions (500 and 300 mg of protein, respectively) in lysing
buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
10% glycerol, 0.5% Nonidet P-40, 1 mM MgCl2, 1 mM PMSF,
5 mg/ml leupeptin, 5 mg/ml pepstatin, 5 mg/ml aprotinin, 25 mM
NaF and 1 mM sodium orthovanadate, pH 7.4). Fractions were
rocked for 2 h at 4uC and the immunocomplexes captured with
protein A/G-agarose (Santa Cruz) or protein G-agarose (Sigma).
Beads were washed in lysing buffer, boiled in loading buffer and
run on SDS-PAGE.
Kinase activity assay
In vitro phosphorylation assays were carried out without DTT
[53]. GST-hERK2 was utilized and JNK1/2, p38 and the
MAPKKs were immunoprecipitated in kinase buffer (20 mM
HEPES, 2.5 mM MgCl2, 10 mM EDTA, 1% NP-40, 0.1% SDS,
40 mM b-glycerophosphate, 2 mM sodium ortovanadate, prote-
ase inhibitors, pH 7.5). Myelin basic protein (MBP) and ATF-2
were used as substrates for ERK2 or JNK1/2 and p38,
respectively and phosphorylation was assessed by autoradiogra-
phy. When appropriate, MAPKs were previously oxydized with
0.1–10 mMo fH 2O2 for 15 min. In mock experiments recombi-
nant MAPKs kinases were absent.
Pull down assay
Cytosolic or mitochondrial fractions were incubated with
human recombinant ERK2-GST, p38-GST or JNK2-GST
(Stressgen) oxidized with H2O2 and bound to agarose in lysing
buffer for 2 h at 4uC. After incubation, agarose beads were washed
in lysing buffer and cracked in loading buffer. Finally, samples
were run on SDS-PAGE and detection of MAPKKs was assessed.
To block the cysteines, proteins were incubated with 4-
vinylpyridine (Sigma-Aldrich) for 1 h at RT, and then washed
and oxidized. In mock experiments recombinant MAPKs kinases
were absent.
Mass spectrometry
Human ERK2, p38 or JNK2 proteins (Upstate) oxidized with
0.1–20 mMH 2O2 were analyzed by mass spectrometry. We used
the mutant non-phosphorylatable ERK K52R to avoid autopho-
sphorylation and its putative effect on ERK oxidation. Tryptic
digestion was performed with methylated trypsin to reduce
autolysis (Promega, Madison, WI). Digestion products were dried
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(Millipore CB18B, Millipore, Billerica, MA) and resuspended in
60% acetic acid for injection by autosampler (Surveyor, Thermo-
Finnigan). Mass analysis was done in a ThermoFinnigan LCQ
Deca XP Plus ion trap mass spectrometer equipped with a
nanospray ion source (ThermoFinnigan). Proteins were identified
with MS/MS Mascot (Matrix Science) search software using
TurboSequest. Mascot and Sequest searches allowed for variable
modifications as methionine, histidine or tryptophan oxidation
(+16 Da) and cysteic acid reduction (+48 Da), and tyrosine and
tryptophan nitrosylation (+45 Da). Sequest search also included
variable mono and di-oxidation of cysteine (+16 and +32,
respectively).
Supporting Information
Figure S1 Redistribution of MAPKKs upon redox stimulation.
Cellular distribution of (A) MEK1/2 (B) MKK4, and (C) MKK3
was followed as in Fig. 3. In (B) and (C), squares represent nuclei
and circles represent mitochondria; red and black symbols indicate
1 and 50 mMH 2O2, respectively. (D) On the bases of the
experimental findings, a representative scheme proposes a cycle of
MPKKs to transport cognate kinases from mitochondria to
nucleus. Green circles indicate that MAPK are preferentially
bound to upstream MAPKKs at the different redox states,
respectively
Found at: doi:10.1371/journal.pone.0002379.s001 (7.40 MB TIF)
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